'We Need to Move Forward': CGM in Diabetes

COMMENTARY

'We Need to Move Forward': Continuous Glucose Monitoring in Diabetes

Anne L. Peters, MD

Disclosures

November 07, 2016

5
This feature requires the newest version of Flash. You can download it here.

Hi. Today I am going to discuss the Endocrine Society guidelines[1] for the use of devices in the treatment of diabetes. I was fortunate enough to be the chairwoman for this committee and it was a wonderful experience, in part because I had such great committee members with whom I worked.

The bottom line of our recommendation was not only that technology is advancing, but that there are tools that should be available to most patients with type 1 diabetes and some patients with type 2 diabetes.

The fundamental premise that we all came to is the true need for patients to have access to continuous glucose monitoring. This is a monitor that is placed on the patient's body for about a week and gives a signal with interstitial blood glucose levels to a receiver (it could be an iPhone or a pump) so that patients can see their blood glucose levels every 5 minutes and see the trends as blood sugar levels rise and fall.

I am at the point where I use these so much with my type 1 diabetes patients that I almost have a problem not having a patient bring me their sensor data. Back in the old days, we used to think that everybody should have finger sticks and bring their finger-stick data in.

Comments

3090D553-9492-4563-8681-AD288FA52ACE
Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.

processing....